These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine. Shinefield HR; Black S; Kuter BJ J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390 [TBL] [Abstract][Full Text] [Related]
4. Live varicella vaccine in healthy individuals. Just M; Berger R; Luescher D Postgrad Med J; 1985; 61 Suppl 4():129-32. PubMed ID: 3014469 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials. Leung JH; Hirai HW; Tsoi KK Expert Rev Vaccines; 2015; 14(8):1149-57. PubMed ID: 26081133 [TBL] [Abstract][Full Text] [Related]
6. A new combination vaccine for measles, mumps, rubella and varicella. Zareba G Drugs Today (Barc); 2006 May; 42(5):321-9. PubMed ID: 16801995 [TBL] [Abstract][Full Text] [Related]
7. Jeryl Lynn Strain Live Attenuated Mumps Virus vaccine in a private pediatric practice. Nickey LN; Huchton P; McGee WG South Med J; 1970 Mar; 63(3):306-8. PubMed ID: 4905918 [No Abstract] [Full Text] [Related]
8. Long-term epidemiologic longitudinal study on the effect of vaccines on public inoculation. Matsuoka I; Matsuoka T; Matsuoka A; Shigemura T; Agematsu K; Koike K Turk J Pediatr; 2012; 54(4):376-81. PubMed ID: 23692718 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients. Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961 [TBL] [Abstract][Full Text] [Related]
13. Prospective Study of Live Attenuated Vaccines for Patients with Nephrotic Syndrome Receiving Immunosuppressive Agents. Kamei K; Miyairi I; Ishikura K; Ogura M; Shoji K; Funaki T; Ito R; Arai K; Abe J; Kawai T; Onodera M; Ito S J Pediatr; 2018 May; 196():217-222.e1. PubMed ID: 29499990 [TBL] [Abstract][Full Text] [Related]
14. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox]. Buxbaum S; Doerr HW; Allwinn R Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730 [TBL] [Abstract][Full Text] [Related]
15. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Marin M; Broder KR; Temte JL; Snider DE; Seward JF; MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine. Just M; Berger R; Just V Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863 [TBL] [Abstract][Full Text] [Related]
17. Application of live attenuated measles and mumps vaccines in children with acute leukemia. Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040 [TBL] [Abstract][Full Text] [Related]
18. Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants. Yerkovich ST; Rowe J; Richmond P; Suriyaarachchi D; Heaton T; Hollams E; Ladyman C; Serralha M; Sadowska A; Loh R; Wesselingh SL; Sly PD; Holt PG Vaccine; 2007 Feb; 25(10):1764-70. PubMed ID: 17224218 [TBL] [Abstract][Full Text] [Related]